Michel Pierre, Di Fiore Frédéric
Unité d'oncologie urodigestive, service d'hépato-gastroentérologie, Hôpital universitaire, 1, rue de Germont, 76031 Rouen Cedex, France.
Bull Cancer. 2008 Jan;95(1):117-20. doi: 10.1684/bdc.2008.0573.
Results published in 2007 improve treatments in digestive oncology. In esophageal cancer, efficacy of preoperative chemotherapy or radiochemotherapy is confirmed. In locally advanced esophageal cancer it has been proved that the definitive radiochemotherapy is an alternative at radiochemotherapy plus surgery. Two majors data have been presented for patients with metastatic colorectal cancer: monochemotherapy for the first line is back; molecular marker is necessary to optimize the use of anti EGFR antibody. Lastly, the first effective medical treatment of hepatocellular carcinoma has been presented.